Trial intelligence / Profile preview

Aripiprazole Augmentation in Refractory Schizophrenia

NCT00328367Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Dec 2005
Primary completion
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Seoul National University Hospital. Started Dec 2005; status: completed.

02

Drugs

aripiprazole
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00328367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00328367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call